Cargando…

VERDICT MRI validation in fresh and fixed prostate specimens using patient‐specific moulds for histological and MR alignment

The VERDICT framework for modelling diffusion MRI data aims to relate parameters from a biophysical model to histological features used for tumour grading in prostate cancer. Validation of the VERDICT model is necessary for clinical use. This study compared VERDICT parameters obtained ex vivo with h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bailey, Colleen, Bourne, Roger M., Siow, Bernard, Johnston, Edward W., Brizmohun Appayya, Mrishta, Pye, Hayley, Heavey, Susan, Mertzanidou, Thomy, Whitaker, Hayley, Freeman, Alex, Patel, Dominic, Shaw, Greg L., Sridhar, Ashwin, Hawkes, David J., Punwani, Shonit, Alexander, Daniel C., Panagiotaki, Eleftheria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519204/ https://www.ncbi.nlm.nih.gov/pubmed/30779863 http://dx.doi.org/10.1002/nbm.4073

Ejemplares similares

Apparatus for Histological Validation of In Vivo and Ex Vivo Magnetic Resonance Imaging of the Human Prostate
por: Bourne, Roger M., et al.
Publicado: (2017)

VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient
por: Johnston, Edward W., et al.
Publicado: (2019)

Joint estimation of relaxation and diffusion tissue parameters for prostate cancer with relaxation-VERDICT MRI
por: Palombo, Marco, et al.
Publicado: (2023)

Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models
por: Sen, Snigdha, et al.
Publicado: (2022)

VERDICT‐AMICO: Ultrafast fitting algorithm for non‐invasive prostate microstructure characterization
por: Bonet‐Carne, Elisenda, et al.
Publicado: (2018)

Optimization and repeatability of multipool chemical exchange saturation transfer MRI of the prostate at 3.0 T
por: Evans, Vincent Stephen, et al.
Publicado: (2019)

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
por: Pye, Hayley, et al.
Publicado: (2021)

Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study
por: Bailey, Colleen, et al.
Publicado: (2016)

INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer
por: Johnston, Edward, et al.
Publicado: (2016)

Multi-parametric MRI zone-specific diagnostic model performance compared with experienced radiologists for detection of prostate cancer
por: Dikaios, Nikolaos, et al.
Publicado: (2018)

Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition
por: Rogers, Harriet J., et al.
Publicado: (2023)

Comprehensive Brain Tumour Characterisation with VERDICT-MRI: Evaluation of Cellular and Vascular Measures Validated by Histology
por: Figini, Matteo, et al.
Publicado: (2023)

The Informed Verdict
Publicado: (1918)

PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens
por: Heavey, Susan, et al.
Publicado: (2019)

Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer
por: Singh, Saurabh, et al.
Publicado: (2022)

Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype
por: Simpson, Benjamin S., et al.
Publicado: (2020)

Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype
por: Simpson, Benjamin S., et al.
Publicado: (2020)

Simplified Luminal Water Imaging for the Detection of Prostate Cancer From Multiecho T(2) MR Images
por: Devine, William, et al.
Publicado: (2018)

Verdicts on the High Life
por: Miles, George
Publicado: (1972)

Verdict of Court-Martial
Publicado: (1885)

Verdict spotting: investigating the effects of juror bias, evidence anchors and verdict system in jurors
por: Curley, Lee J., et al.
Publicado: (2021)

Limitations and Prospects for Diffusion-Weighted MRI of the Prostate
por: Bourne, Roger, et al.
Publicado: (2016)

The oncological relevance of fragile sites in cancer
por: Simpson, Benjamin S., et al.
Publicado: (2021)

Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists
por: Antonelli, Michela, et al.
Publicado: (2019)

The Commissioner's Summing-Up, and the Verdict
Publicado: (1852)

Nature Renders a Verdict
Publicado: (1900)

Verdict of a Coroner’s Jury
Publicado: (1885)

NICE verdict on Temozolomide: where next?
por: Brada, M
Publicado: (2002)

On Suicide—Verdicts of Felo-de-se
Publicado: (1850)

Cheap Advertising Dentists—Extraordinary Verdict
Publicado: (1851)

Critical Examination of the Evidence, Arguments, Verdict, &c
Publicado: (1829)

Percutaneous Nephrolithotomy: Which Position? The Referee’s Verdict
por: Knoll, Thomas
Publicado: (2021)

The Verdict of Science Concerning the Effects of Alcohol on Man
por: Davis, N. S.
Publicado: (1875)

National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection – recommendations from a UK consensus meeting
por: Brizmohun Appayya, Mrishta, et al.
Publicado: (2018)

Complementary and Alternate Management of Glaucoma: The Verdict so Far
por: Bhartiya, Shibal, et al.
Publicado: (2014)

Fact or Fiction, It Is Time for a Verdict on Vasculogenic Mimicry?
por: Valdivia, Andrés, et al.
Publicado: (2019)

An optimised saliva collection method to produce high-yield, high-quality RNA for translational research
por: Sullivan, Roisin, et al.
Publicado: (2020)

Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

'Libyan Trial': a verdict running counter to scientific evidence
por: Fleutelot, Eric
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_p9hisi454j6smh3sfo0pvgovvs